What is your approach to steroid sparing therapy in patients with suspected CTD-ILD?
Answer from: at Academic Institution
It depends on numerous factors:
What's the underlying CTD?
Has the patient been trialed on immunomodulatory agents before?
What's the risk of therapy in this patient?
And many others. It's a big topic. To delve into some of the above by bullet point:
Most guidance for immune suppression is driv...
Sign in or Register to read more
Answer from: at Community Practice
If there is no active infection, I would try to get ahead of the progressive lung fibrosis with rituximab, and if successful, then reconsider alternatives.